The industry is aware of the racial and ethnic imbalance in clinical trials and its consequences. Discover how inclusive trial design can lead to better patient outcomes and more representative results.
Given the decentralization of clinical trials and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”
Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.
Derk Arts, Founder and CEO of Castor, and Kimberly Tableman, Castor’s Chief Clinical Development Officer, discuss what changes are expected in clinical research, technology, and data through the lens of three key pillars.
If you’re looking for TMF services support but don’t know where to start, this guide can help you ask the right questions and select a partner who understands your organization, supports your goals and objectives, and assists in maintaining constant TMF inspection readiness.